Cargando…

Novel Multiple miRNA-Based Signatures for Predicting Overall Survival and Recurrence-Free Survival of Colorectal Cancer Patients

BACKGROUND: Colorectal cancer (CRC) has become a heavy health burden around the world, accounting for about 10% of newly diagnosed cancer cases. In the present study, we aimed to establish the miRNA-based prediction signature to assess the prognosis of CRC patients. MATERIAL/METHODS: A total of 451...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Jinrong, Zeng, Lifeng, Jiang, Xiaohua, Zhang, Zhiyong, Luo, Xiaojiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2019
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778412/ https://www.ncbi.nlm.nih.gov/pubmed/31560680 http://dx.doi.org/10.12659/MSM.916948

Ejemplares similares

Long non-coding FAM201A accelerates the tumorigenesis and progression of colorectal cancer through miR-3163/MACC1 axis
por: Zeng, Lifeng, et al.
Publicado: (2022)

Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer
por: Varkaris, Andreas, et al.
Publicado: (2019)

Recurrence‐associated gene signature optimizes recurrence‐free survival prediction of colorectal cancer
por: Tian, Xianglong, et al.
Publicado: (2017)

A Novel Risk-Score Model With Eight MiRNA Signatures for Overall Survival of Patients With Lung Adenocarcinoma
por: Wu, Jun, et al.
Publicado: (2021)

Evaluating relapse-free survival as an endpoint for overall survival in adjuvant immunotherapy trials
por: Li, Yuanfang, et al.
Publicado: (2023)

A seven-gene signature predicts overall survival of patients with colorectal cancer
por: Chen, Huarong, et al.
Publicado: (2016)

A novel lncRNA-mRNA-miRNA signature predicts recurrence and disease-free survival in cervical cancer
por: Li, Mengxiong, et al.
Publicado: (2021)

A 16-miRNA Prognostic Model to Predict Overall Survival in Neuroblastoma
por: Wang, Jiepin, et al.
Publicado: (2022)

Application of miRNA Biomarkers in Predicting Overall Survival Outcomes for Lung Adenocarcinoma
por: Li, Tingting, et al.
Publicado: (2022)

Radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of overall survival and recurrence-free survival
por: Gardini, Andrea Casadei, et al.
Publicado: (2018)

A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma
por: Zhang, Shu-Wen, et al.
Publicado: (2022)

A 4-miRNA signature to predict survival in glioblastomas
por: Hermansen, Simon K., et al.
Publicado: (2017)

Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer
por: Cicero, Giuseppe, et al.
Publicado: (2018)

Necroptosis-Related miRNA Biomarkers for Predicting Overall Survival Outcomes for Endometrial Cancer
por: Song, Hualin, et al.
Publicado: (2022)

A Novel Prognostic Model Based on Seven Necroptosis-Related miRNAs for Predicting the Overall Survival of Patients with Lung Adenocarcinoma
por: Hong, Xiaohua, et al.
Publicado: (2022)

Identification of the miRNA signature associated with survival in patients with ovarian cancer
por: Sathipati, Srinivasulu Yerukala, et al.
Publicado: (2021)

Survival associated miRNA signature in patients with head and neck carcinomas
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2023)

Surgery for colorectal liver metastases: the impact of resection margins on recurrence and overall survival
por: Angelsen, Jon-Helge, et al.
Publicado: (2014)

Nomograms integrating CT radiomic and deep learning signatures to predict overall survival and progression-free survival in NSCLC patients treated with chemotherapy
por: Chang, Runsheng, et al.
Publicado: (2023)

Recurrence-free survival as a putative surrogate for overall survival in phase III trials of curative-intent treatment of colorectal liver metastases: Systematic review
por: Araujo, Raphael L C, et al.
Publicado: (2017)

Weighted miRNA co-expression networks analysis identifies circulating miRNA predicting overall survival in hepatocellular carcinoma patients
por: Pascut, Devis, et al.
Publicado: (2020)

The Landscape of Using Glycosyltransferase Gene Signatures for Overall Survival Prediction in Hepatocellular Carcinoma
por: Cai, Qiang, et al.
Publicado: (2022)

Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma
por: Liu, Xi, et al.
Publicado: (2018)

Epigenetic Alterations Associated with the Overall Survival and Recurrence Free Survival among Oral Squamous Cell Carcinoma Patients
por: Ghantous, Yasmen, et al.
Publicado: (2020)

Dynamic Expression of 11 MiRNAs in 83 Consecutive Primary and Corresponding Recurrent Glioblastoma: Correlation to Treatment, Time to Recurrence, Overall Survival and MGMT Methylation Status
por: Matos, Bostjan, et al.
Publicado: (2018)

Methylation-to-Expression Feature Models of Breast Cancer Accurately Predict Overall Survival, Distant-Recurrence Free Survival, and Pathologic Complete Response in Multiple Cohorts
por: Thompson, Jeffrey A., et al.
Publicado: (2018)

Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2017)

The Disease-Free Interval Between Resection of Primary Colorectal Malignancy and the Detection of Hepatic Metastases Predicts Disease Recurrence But Not Overall Survival
por: Höppener, Diederik J., et al.
Publicado: (2019)

CGB5 expression is independently associated with poor overall survival and recurrence‐free survival in patients with advanced gastric cancer
por: Yang, Yuxin, et al.
Publicado: (2018)

Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patients
por: Chan, Owen T.M., et al.
Publicado: (2017)

Conditional Survival of Surgically Treated Patients with Lung Cancer: A Comprehensive Analyses of Overall, Recurrence-Free, and Relative Survival
por: Shin, Dong Wook, et al.
Publicado: (2021)

Prognostic Value of Preoperative Serum Carcinoembryonic Antigen for Overall Survival and Recurrence-Free Survival in Resectable Thymic Epithelial Tumors
por: Huang, Yang-Yu, et al.
Publicado: (2022)

Metabolic Parameters as Predictors for Progression Free and Overall Survival of Patients with Metastatic Colorectal Cancer
por: Nemeth, Zsuzsanna, et al.
Publicado: (2020)

Identification of prognostic immune-related lncRNA signature predicting the overall survival for colorectal cancer
por: Li, Jianxin, et al.
Publicado: (2023)

Development of lactate‐related gene signature and prediction of overall survival and chemosensitivity in patients with colorectal cancer
por: Tong, Zhi, et al.
Publicado: (2023)

A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma
por: Huang, Guo-Wei, et al.
Publicado: (2018)

A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy
por: Rajakumar, Timothy, et al.
Publicado: (2022)

Prognostic significance of sarcopenia diagnosed based on the anthropometric equation for progression-free survival and overall survival in patients with colorectal cancer
por: Xie, Hailun, et al.
Publicado: (2023)

Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population
por: Sørrig, Rasmus, et al.
Publicado: (2017)

Identification of Prognostic Signatures for Predicting the Overall Survival of Uveal Melanoma Patients
por: Xue, Meijuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cph7d9rmke094vcqfduqdu1si0